Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alexander A. Fitzpatrick currently holds 90,910 shares of ARS Pharmaceuticals, Inc. (SPRY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alexander A. Fitzpatrick has been a net buyer of SPRY stock. They have purchased $385.0K and sold $33.5K worth of shares.
Alexander A. Fitzpatrick's most recent insider trade was on Jun 12, 2026, when they sold 3,355 shares at $10.00 per share.
Alexander A. Fitzpatrick serves as Executive at ARS Pharmaceuticals, Inc. (SPRY). They have executed 30 insider transactions totaling $418.5K over their tenure at the company.
Alexander A. Fitzpatrick holds the position of Executive at ARS Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Alexander A. Fitzpatrick has shown a buying trading pattern, with $385.0K in total purchases and $33.5K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Alexander A. Fitzpatrick was on May 22, 2020, when they sold $197.0K worth of EVFM shares. This transaction involved 39,487 shares at $4.99 per share.
Alexander A. Fitzpatrick currently owns 90,910 shares of ARS Pharmaceuticals, Inc. (SPRY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alexander A. Fitzpatrick's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alexander A. Fitzpatrick has 30 Form 4 filings on record as an insider at ARS Pharmaceuticals, Inc..
Set alerts for Alexander A. Fitzpatrick and 40,000+ other insiders.